Motilal Oswal Alternates invests $72 M in Sensa Core Medical Instrumentation

Motilal Oswal Alternates has announced a significant minority investment of $72 million in Sensa Core, an innovation driven medical devices’ company focused on advancing healthcare technology in India.

Founded in Hyderabad in 2006, Sensa Core is engaged in design (IP-driven), development, manufacturing and distribution of specialised in-vitro diagnostic devices. Started as a fully bootstrapped venture, the company has evolved into a market leader in Electrolyte Analysers, achieving wide adoption across more than 40,000 hospitals/diagnostic labs in India and exports to over 78 countries.

Sensa Core is also one of the leading Indian players in Glucometers, Haemoglobin meters and has recently forayed in Arterial Blood gas Analysers. The company operates a dedicated manufacturing facility in Hyderabad’s Export Promotion Industrial Park, Pashamylaram and will be commissioning a new manufacturing facility in Medical Device Park, Sultanpur, Hyderabad to augment capacity & build capability for new products.

The investment will enable Sensa Core to accelerate product development and expand its footprint globally, further strengthening its position as one of the leading players in the IVD segment.